Follow
Sidhartha Mahali
Sidhartha Mahali
Cell and Molecular Biologist
Verified email at rush.edu - Homepage
Title
Cited by
Cited by
Year
ELAVL4, splicing, and glutamatergic dysfunction precede neuron loss in MAPT mutation cerebral organoids
KR Bowles, MC Silva, K Whitney, T Bertucci, JE Berlind, JD Lai, JC Garza, ...
Cell 184 (17), 4547-4563. e17, 2021
1112021
Advanced glycation end products (AGEs) induce apoptosis via a novel pathway: involvement of Ca2+ mediated by interleukin-8 protein
S Mahali, N Raviprakash, PB Raghavendra, SK Manna
Journal of Biological Chemistry 286 (40), 34903-34913, 2011
722011
Advanced Glycation End Products Induce Lipogenesis: Regulation by Natural Xanthone through Inhibition of ERK and NF‐κB
SK Mahali, N Verma, SK Manna
Journal of cellular physiology 229 (12), 1972-1980, 2014
332014
Glioblastoma multiforme: novel therapeutic approaches
AM Fialho, P Salunkhe, S Manna, S Mahali, AM Chakrabarty
International Scholarly Research Notices 2012 (1), 642345, 2012
302012
A natural xanthone increases catalase activity but decreases NF-kappa B and lipid peroxidation in U-937 and HepG2 cell lines
BK Sahoo, AH Zaidi, P Gupta, RB Mokhamatam, N Raviprakash, ...
European journal of pharmacology 764, 520-528, 2015
292015
Defects in lysosomal function and lipid metabolism in human microglia harboring a TREM2 loss of function mutation
Acta Neuropathologica, 2023
25*2023
Beta-D-glucoside protects against advanced glycation end products (AGEs)-mediated diabetic responses by suppressing ERK and inducing PPAR gamma DNA binding
SK Mahali, SK Manna
Biochemical pharmacology 84 (12), 1681-1690, 2012
232012
Conserved gene signatures shared among MAPT mutations reveal defects in calcium signaling
MA Minaya, S Mahali, AK Iyer, AM Eteleeb, R Martinez, G Huang, J Budde, ...
Frontiers in Molecular Biosciences 10, 1051494, 2023
112023
Defective proteostasis in induced pluripotent stem cell models of frontotemporal lobar degeneration
S Mahali, R Martinez, M King, A Verbeck, O Harari, BA Benitez, K Horie, ...
Translational psychiatry 12 (1), 508, 2022
92022
Defective proteostasis in patient-derived iPSC-astrocytes and neurons carrying a MAPT IVS10+ 16 mutation
S Mahali, C Karch
Alzheimers Dement 17 (e054448), 2021
32021
Anticancer agent
A Suri, D Kanojia, P Salunkhe, S Mahali, SK Manna, A Surolia, ...
US Patent 9,624,277, 2017
22017
Defective proteostasis in patient-derived iPSC-astrocytes and neurons carrying a MAPT IVS10+16 mutation
Annual Hope Center Retreat, 2022
2022
KIF18A plus end spatio-temporal regulation by Aurora B & PP1 during (pro)- metaphase is required for proper mitosis
S Mahali, B Lesage, GVD Hoeven, M Beullens, M Bollen
Researchgate, 2022
2022
Lysosomal Dysfunction in Stem Cell Models of Tauopathy
CM Karch, S Mahali, S Jiang, S Hsu, B Benitez, O Harari, C Cruchaga
ANNALS OF NEUROLOGY 86, S147-S148, 2019
2019
O3‐07‐02: LYSOSOMAL DYSFUNCTION IN STEM CELL MODELS OF TAUOPATHY
S Mahali, S Jiang, S Hsu, B Benitez, O Harari, C Cruchaga, CM Karch
Alzheimer's & Dementia 15, P897-P898, 2019
2019
O2‐12‐01: LYSOSOMAL DYSFUNCTION AND ALTERED TAU METABOLISM IN STEM CELL MODELS OF AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE
S Mahali, S Hsu, B Benitez, R Martinez, AM Goate, C Karch, DIAN
Alzheimer's & Dementia 14 (7S_Part_12), P650-P650, 2018
2018
Understanding advanced glycation end product-mediated cell signaling and its regulation
SK Mahali
Manipal, 0
The system can't perform the operation now. Try again later.
Articles 1–17